Mucositis por radioterapia
Terapia coadyuvante
La L-glutamina se usa para prevenir la mucositis oral durante la quimio- y radioterapia. MASCC/ISOO 2019 dio una recomendación positiva (sugerencia a favor) para la glutamina oral en la mucositis por radioterapia de cabeza y cuello; varios metaanálisis mostraron menor gravedad de la mucositis grave. Para la vía parenteral en el trasplante de células madre hematopoyéticas la recomendación es negativa. ASCO y ESPEN la consideran soporte opcional. La glutamina es inocua; el oncólogo decide dosis y forma en el uso de soporte.
Sources
- Support Care Cancer: Systematic review of natural and miscellaneous agents for the management of oral mucositis in cancer patients and clinical practice guidelines-part 1: vitamins, minerals, and nutritional supplements. (2019)
- Nutr Cancer: Role of Glutamine in the Management of Oral Mucositis in Patients with Cancer: A Meta-Analysis of Randomized Controlled Trials. (2022)
- Support Care Cancer: Effectiveness of glutamine in the management of oral mucositis in cancer patients: a meta-analysis of randomized controlled trials. (2021)
- Front Nutr: Oral Glutamine May Have No Clinical Benefits to Prevent Radiation-Induced Oral Mucositis in Adult Patients With Head and Neck Cancer: A Meta-Analysis of Randomized Controlled Trials. (2020)